MetLife Investment Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.92M | Sell |
|
|||||
|
2025
Q1 | $1.68M | Sell |
|
|||||
|
2024
Q4 | $1.38M | Buy |
|
|||||
|
2024
Q3 | $1.52M | Hold |
|
|||||
|
2024
Q2 | $1.17M | Buy |
|
|||||
|
2024
Q1 | $827K | Hold |
|
|||||
|
2023
Q4 | $656K | Hold |
|
|||||
|
2023
Q3 | $477K | Hold |
|
|||||
|
2023
Q2 | $790K | Buy |
|
|||||
|
2023
Q1 | $550K | Hold |
|
|||||
|
2022
Q4 | $261K | Hold |
|
|||||
|
2022
Q3 | $202K | Hold |
|
|||||
|
2022
Q2 | $189K | Hold |
|
|||||
|
2022
Q1 | $566K | Buy |
|
|||||
|
2021
Q4 | $516K | Hold |
|
|||||
|
2021
Q3 | $267K | Hold |
|
|||||
|
2021
Q2 | $677K | Buy |
|
|||||
|
2021
Q1 | $350K | Hold |
|
|||||
|
2020
Q4 | $273K | Hold |
|
|||||
|
2020
Q3 | $264K | Buy |
|
|||||
|
2020
Q2 | $191K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $109K | Buy |
|